BACKGROUND Chronic gastritis(CG)is a common gastrointestinal disorder characterized by inflammation of the stomach lining.Liver-stomach disharmony(LSD)syndrome is believed to contribute to CG symptoms.AIM To evaluate ...BACKGROUND Chronic gastritis(CG)is a common gastrointestinal disorder characterized by inflammation of the stomach lining.Liver-stomach disharmony(LSD)syndrome is believed to contribute to CG symptoms.AIM To evaluate the efficacy and safety of microcosmic syndrome differentiation and Chinese herbal medicine(CHM)treatment in patients with CG and LSD syndrome.METHODS Sixty-four patients with CG and LSD syndrome were randomly divided into two groups:The treatment group received CHM based on microcosmic syndrome differentiation and the control group received conventional Western medicine.The treatment course lasted 12 wk.The primary outcome was improvement in dyspeptic symptoms,measured using the Nepean Dyspepsia Index.The secondary outcomes included the improvement rate of endoscopic findings,histopathological findings,and microcosmic syndrome scores and the incidence of adverse events.RESULTS After 12 wk of treatment,the treatment group showed significantly greater improvement in dyspeptic symptoms than the control group(93.75%vs 65.63%,P<0.01).The treatment group also showed a significantly higher improvement rate in endoscopic findings than the control group(81.25%vs 53.13%,P<0.05).The improvement rates of histopathological findings and microcosmic syndrome scores were not significantly different between the two groups(P>0.05).No serious adverse events were observed in either group.CONCLUSION Microcosmic syndrome differentiation and CHM treatment can effectively improve dyspeptic symptoms and endoscopic findings in patients with CG and LSD syndrome and have a good safety profile.Further studies with larger sample sizes and longer follow-up periods are required to confirm the long-term efficacy and mechanism of action of this treatment.展开更多
Objective:To explore the clinical effect of integrated traditional Chinese and Western medicine in the treatment of liver-stomach disharmony functional dyspepsia.Methods:Sixty patients with functional dyspepsia of liv...Objective:To explore the clinical effect of integrated traditional Chinese and Western medicine in the treatment of liver-stomach disharmony functional dyspepsia.Methods:Sixty patients with functional dyspepsia of liver-stomach disharmony type admitted to our hospital from January to August 2022 were selected as research subjects and randomly divided into two groups,a study group and a control group,with 30 cases in each group.The main observations were stomachache or pain over bilateral flanks,emotionally depressed,belching,fullness and discomfort over the abdomen and flanks,acid regurgitation,loss of appetite,frequent sighing,noisy epigastric,and the treatment effect.Results:According to the classification of symptom severity on the traditional Chinese medicine(TCM)symptom score table,statistics were made on the corresponding severity of the main symptoms and secondary symptoms of the two groups of patients,and the data of the two groups were compared by Wilcoxon test.The results showed that there was no significant difference in the distribution of TCM symptoms between the two groups;the study group’s total effective rate of pain relief(recovery+markedly effective+effective)was 96.67%,and Fisher’s χ^(2) test indicated a significant difference in the total effective rate of pain relief between the two groups(P=0.027<0.05).Conclusion:The use of integrated traditional Chinese and western medicine is clearly better than the simple application of western medicine.It is safe and has no side effects.It can be used as a treatment for patients with functional dyspepsia.展开更多
目的探讨超声影像组学模型鉴别肝郁痰凝型与冲任失调型乳腺癌中医证型的价值,寻求有助于中医辨证分型的客观指标。方法回顾性收集2018年1月—2021年12月于福建中医药大学附属第二人民医院行术前超声检查并经病理确诊且有完整中医辨证资...目的探讨超声影像组学模型鉴别肝郁痰凝型与冲任失调型乳腺癌中医证型的价值,寻求有助于中医辨证分型的客观指标。方法回顾性收集2018年1月—2021年12月于福建中医药大学附属第二人民医院行术前超声检查并经病理确诊且有完整中医辨证资料的231例(247个病灶)乳腺癌患者资料,获取术前超声图像,用ITK-SNAP软件勾画感兴趣区(ROI),利用Pyradiomics 3.0软件提取超声影像组学特征,病灶按7∶3比例分为训练集(175个)和测试集(72个),使用最小绝对收缩与选择算法(LASSO)进行特征降维筛选,采用支持向量机(SVM)构建影像组学模型,通过受试者工作特征(ROC)曲线评估模型的鉴别诊断效能。结果纳入病例中肝郁痰凝型107例115个病灶,冲任失调型124例132个病灶。LASSO算法筛选出17个可鉴别肝郁痰凝型和冲任失调型乳腺癌的超声影像组学特征,其中前7个特征权重系数较大,分别为Dependence Variance,Correlation,Sphericity,Center Of MassIndex2,Bounding Box5,Large Dependence High Gray Level Emphasis和Short Run Emphasis。利用上述17个有效特征构建的影像组学模型在训练集和测试集上的曲线下面积(AUC)分别为0.797(95%CI:0.730~0.864)和0.775(95%CI:0.666~0.883)。该模型训练集的敏感度、特异度、准确率分别为72.3%(60/83)、73.0%(65/89)、72.7%(125/172);该模型测试集的敏感度、特异度、准确率分别为75.5%(37/49)、65.4%(17/26)、72.0%(54/75)。结论超声影像组学模型能够有效鉴别肝郁痰凝型与冲任失调型乳腺癌,筛选出的影像组学特征可作为乳腺癌中医辨证分型的微观指标。展开更多
文摘BACKGROUND Chronic gastritis(CG)is a common gastrointestinal disorder characterized by inflammation of the stomach lining.Liver-stomach disharmony(LSD)syndrome is believed to contribute to CG symptoms.AIM To evaluate the efficacy and safety of microcosmic syndrome differentiation and Chinese herbal medicine(CHM)treatment in patients with CG and LSD syndrome.METHODS Sixty-four patients with CG and LSD syndrome were randomly divided into two groups:The treatment group received CHM based on microcosmic syndrome differentiation and the control group received conventional Western medicine.The treatment course lasted 12 wk.The primary outcome was improvement in dyspeptic symptoms,measured using the Nepean Dyspepsia Index.The secondary outcomes included the improvement rate of endoscopic findings,histopathological findings,and microcosmic syndrome scores and the incidence of adverse events.RESULTS After 12 wk of treatment,the treatment group showed significantly greater improvement in dyspeptic symptoms than the control group(93.75%vs 65.63%,P<0.01).The treatment group also showed a significantly higher improvement rate in endoscopic findings than the control group(81.25%vs 53.13%,P<0.05).The improvement rates of histopathological findings and microcosmic syndrome scores were not significantly different between the two groups(P>0.05).No serious adverse events were observed in either group.CONCLUSION Microcosmic syndrome differentiation and CHM treatment can effectively improve dyspeptic symptoms and endoscopic findings in patients with CG and LSD syndrome and have a good safety profile.Further studies with larger sample sizes and longer follow-up periods are required to confirm the long-term efficacy and mechanism of action of this treatment.
文摘Objective:To explore the clinical effect of integrated traditional Chinese and Western medicine in the treatment of liver-stomach disharmony functional dyspepsia.Methods:Sixty patients with functional dyspepsia of liver-stomach disharmony type admitted to our hospital from January to August 2022 were selected as research subjects and randomly divided into two groups,a study group and a control group,with 30 cases in each group.The main observations were stomachache or pain over bilateral flanks,emotionally depressed,belching,fullness and discomfort over the abdomen and flanks,acid regurgitation,loss of appetite,frequent sighing,noisy epigastric,and the treatment effect.Results:According to the classification of symptom severity on the traditional Chinese medicine(TCM)symptom score table,statistics were made on the corresponding severity of the main symptoms and secondary symptoms of the two groups of patients,and the data of the two groups were compared by Wilcoxon test.The results showed that there was no significant difference in the distribution of TCM symptoms between the two groups;the study group’s total effective rate of pain relief(recovery+markedly effective+effective)was 96.67%,and Fisher’s χ^(2) test indicated a significant difference in the total effective rate of pain relief between the two groups(P=0.027<0.05).Conclusion:The use of integrated traditional Chinese and western medicine is clearly better than the simple application of western medicine.It is safe and has no side effects.It can be used as a treatment for patients with functional dyspepsia.
文摘目的探讨超声影像组学模型鉴别肝郁痰凝型与冲任失调型乳腺癌中医证型的价值,寻求有助于中医辨证分型的客观指标。方法回顾性收集2018年1月—2021年12月于福建中医药大学附属第二人民医院行术前超声检查并经病理确诊且有完整中医辨证资料的231例(247个病灶)乳腺癌患者资料,获取术前超声图像,用ITK-SNAP软件勾画感兴趣区(ROI),利用Pyradiomics 3.0软件提取超声影像组学特征,病灶按7∶3比例分为训练集(175个)和测试集(72个),使用最小绝对收缩与选择算法(LASSO)进行特征降维筛选,采用支持向量机(SVM)构建影像组学模型,通过受试者工作特征(ROC)曲线评估模型的鉴别诊断效能。结果纳入病例中肝郁痰凝型107例115个病灶,冲任失调型124例132个病灶。LASSO算法筛选出17个可鉴别肝郁痰凝型和冲任失调型乳腺癌的超声影像组学特征,其中前7个特征权重系数较大,分别为Dependence Variance,Correlation,Sphericity,Center Of MassIndex2,Bounding Box5,Large Dependence High Gray Level Emphasis和Short Run Emphasis。利用上述17个有效特征构建的影像组学模型在训练集和测试集上的曲线下面积(AUC)分别为0.797(95%CI:0.730~0.864)和0.775(95%CI:0.666~0.883)。该模型训练集的敏感度、特异度、准确率分别为72.3%(60/83)、73.0%(65/89)、72.7%(125/172);该模型测试集的敏感度、特异度、准确率分别为75.5%(37/49)、65.4%(17/26)、72.0%(54/75)。结论超声影像组学模型能够有效鉴别肝郁痰凝型与冲任失调型乳腺癌,筛选出的影像组学特征可作为乳腺癌中医辨证分型的微观指标。
